Vitro Biopharma, Inc.

Overview

Vitro Biopharma is an innovative biotechnology company focused on developing Wharton's jelly-derived cell therapies for autoimmune diseases and inflammatory disorders.

Classification

This U.S. industry comprises establishments primarily engaged in manufacturing vaccines, toxoids, blood fractions, and culture media of plant or animal origin (except diagnostic).

1. Manufacturing32
2. Chemical Manufacturing325
3. Pharmaceutical and Medicine Manufacturing32541
4. Biological Product (except Diagnostic) Manufacturing325414